AMOXYCILLIN 200mg. IP + CLAVULANIC ACID 28.5mg. IP

A combination of penicillin-class antibacterial and beta-lactamase inhibitors that treats a wide variety of bacterial infections by stopping the growth of bacteria. A potent broad spectrum of antibacterial activity against aerobic and anaerobic, including beta-lactamase-producing pathogens. (Anthony R White, 2004) The first-line therapy for uncomplicated acute otitis media, sinusitis, and pneumonia because of its activity against Streptococcus pneumoniae and Haemophilus influenza. (Klein, 2003) Exerts high bacteriological and clinical efficacy in respiratory tract infection over more than 20 years. (Anthony R White C. K., 2004) Eradicates or suppresses all penicillin-susceptible and penicillin-intermediate Streptococcus pneumoniae and 73% of penicillin-resistant Streptococcus pneumoniae. (Klein J. O., 2003) An effective drug for a variety of pediatric infectious diseases, including acute otitis media, sinusitis, pneumonia, urinary tract infections, and infections of the skin and soft tissues. (Klein J. O., 2003) Has comparable efficacy to cefaclor for treating uncomplicated urinary tract infections, acute bronchitis, bronchopneumonia, acute sinusitis, otitis media, and skin and soft-tissue infections. (G E Stein, 1984)